William P Kane Jr Karuna Therapeutics, Inc. (KRTX) insider trading activity

KRTX Quotes by TradingView

William P Kane Jr is Chief Commercial Officer of Karuna Therapeutics, Inc.. Currently has a direct ownership of 0 shares of KRTX, which is worth approximately $0. The most recent transaction as insider was on Mar 18, 2024, when has been sold 13,828 shares (Common Stock) at a price of $330.0 per share, resulting in proceeds of $4,563,240. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

William P Kane Jr Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 18 2024
SELL
Sale (or disposition) back to the issuer
$4,563,240 $330.0 p/Share
13,828 Reduced 100.0%
0 Common Stock
Dec 28 2023
SELL
Payment of exercise price or tax liability
$1,210,796 $316.3 p/Share
3,828 Reduced 21.68%
13,828 Common Stock
Feb 06 2023
BUY
Grant, award, or other acquisition
-
17,656 Added 50.0%
17,656 Common Stock

Also insider at

BTAI
BioXcel Therapeutics, Inc. Healthcare
Chief Commercial Officer
WPK

William P Kane Jr

Chief Commercial Officer
New Haven, CT

Track Institutional and Insider Activities on KRTX

Follow Karuna Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KRTX shares.

Notify only if

Insider Trading

Get notified when an Karuna Therapeutics, Inc. insider buys or sells KRTX shares.

Notify only if

News

Receive news related to Karuna Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KRTX